MLAB

Mesa Laboratories, Inc. (MLAB) | Rumor.io

Mesa Laboratories

MLAB

Attention (50-day avg)0%

Attention rank (50-day avg)#3,671

Bullish sentiment (50-day avg)100%

Price to earnings ratio157.6

Market capitalization744.2M

Earnings per share0.84

Dividend yield (TTM)0.48%

Revenue (annual)249.1M

Net income (annual)6.7M

Social

What share of all stock conversation is about MLAB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Jul 23

MLAB stock price is $98.57, up 1.09% from previous days.
The company's stock has experienced a significant surge, with some users describing it as "crazy", "insane", and "absolutely bonkers".
Users are using phrases like "to the moon" and "printing money" to describe the stock's rapid increase, indicating a strong and optimistic sentiment.

Generated by AI

Sentiment

Of the messages about MLAB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	88.89% +79.8
Bearish	—	—	—	11.11% -79.8

Jul 23

Mesa Laboratories, Inc. (MLAB) is experiencing a significant surge, with a 1.09% increase to $98.57.
The stock's momentum is unstoppable, with multiple posts describing the rally as "crazy," "insane," and "absolutely bonkers."
MLAB's breakout is attributed to its printing money and feeling unstoppable, with the stock hitting targets and experiencing a rocket-like rise to the moon.

Generated by AI

Topics

Of the messages about MLAB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	84.85%
Analysts	—	—	0%	0%
Controversies	—	—	0%	3.03%
Earnings	—	—	0%	3.03%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	9.09%

Earnings· Jul 31

Mesa Laboratories, Inc. reported Q1 EPS of $1.06 and revenue of $25.14M, a 10.9% year-over-year increase.
The company's stock price rose 2.85% following the announcement of Q1 earnings.
Mesa Laboratories' Q1 earnings per share (EPS) came in at $1.06, beating expectations.

Announcements· May 31

Mesa Laboratories, Inc. has revised its earnings announcement date for the unaudited fourth quarter and full fiscal year 2024 results.
Trading in $MLAB was halted for the first time on May 31, 2024, due to volatility, but resumed shortly after.
Mesa Laboratories, Inc. recently went ex-dividend, which may be related to the recent price movement in the stock.

Generated by AI

Community

Of the messages about MLAB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	12%	38.16%
Newcomers	—	100%	88%	61.84%

Regulars· Feb 6

Mesa Laboratories reported earnings of $1.96, beating the consensus estimate of $1.49.
The company's Non-GAAP EPS of $2.35 beat expectations, while revenue of $54.29M missed the estimate of $57.04M.
Mesa Laboratories' CEO or Director, John James Sullivan, gifted 14,580 shares of common stock to himself at a price of $0, increasing his holdings to 44,580 shares.

Newcomers· Jul 23

The asset, Mesa Laboratories Inc. (MLAB), is experiencing a significant surge, with its price increasing by 1.09% to $98.57, causing excitement among investors.
The newcomers are attributing the asset's rally to its "crazy surge" and "printing money" vibes, with some users joking about the asset going "to the moon".
The asset's momentum is described as "nuts", "insane", and "absolutely bonkers", with users expressing their excitement and enthusiasm for the stock's rapid growth.

Generated by AI

News

Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript

Detailed price information for Mesa Labs Inc (MLAB-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Mesa Laboratories CEO Kadia buys $800,090 in stock

1mo agoInvesting.com

Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary

Moby summary of Mesa Laboratories, Inc.'s Q1 2027 earnings call

1mo agoYahoo Finance

Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: Margin Expansion and Debt ...

Adjusted operating income surges nearly 20% as the company returns to core organic growth and strengthens its balance sheet.

1mo agoca.finance.yahoo.com

Mesa Laboratories Q1 Earnings Call Highlights

1mo agoYahoo Finance

Earnings call transcript: Mesa Laboratories posts Q1 2026 revenue miss

1mo agoInvesting.com

Also Discussed

Investors talking about MLAB also mention

#	Name	Attention
1	The Hackett Group, Inc.HCKT	0%0
2	RLI Corp.RLI	0%new
3	SCWX - SecureWorks Corp.	——
4	Ituran Location and Control Ltd.ITRN	0%new
5	WKME - WalkMe Ltd.	——
6	International Bancshares Corp.IBOC	0%0
7	SNPO - Snap One Holdings Corp.	——
8	Home BancShares, Inc.HOMB	0%0
9	Cable One Inc.CABO	0%-0.01
10	EB - Eventbrite, Inc.	——

Mesa Laboratories, Inc.

Technology
Scientific & Technical Instruments

Mesa Laboratories, Inc. is a life sciences tools and critical quality control solutions company that develops, manufactures, sells, and services products used in regulated environments. Its portfolio supports monitoring, testing, measurement, and calibration across healthcare, pharmaceutical, food and beverage, and medical device markets. The company’s operations are organized into Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions, reflecting its focus on product safety, process reliability, and compliance. Mesa Laboratories serves customers in North America, Europe, the Asia Pacific, and other international markets, making it an important supplier of specialized instruments, disposable products, and validation tools for quality-sensitive industries. Mesa Laboratories, Inc. is headquartered in Lakewood, Colorado.

Website

Location

12100 West Sixth Avenue

Lakewood, CO, 80228

United States

Social

What share of all stock conversation is about MLAB?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% 0

Jul 23

MLAB stock price is $98.57, up 1.09% from previous days.
The company's stock has experienced a significant surge, with some users describing it as "crazy", "insane", and "absolutely bonkers".
Users are using phrases like "to the moon" and "printing money" to describe the stock's rapid increase, indicating a strong and optimistic sentiment.

Generated by AI

Sentiment

Of the messages about MLAB that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	88.89% +79.8
Bearish	—	—	—	11.11% -79.8

Jul 23

Mesa Laboratories, Inc. (MLAB) is experiencing a significant surge, with a 1.09% increase to $98.57.
The stock's momentum is unstoppable, with multiple posts describing the rally as "crazy," "insane," and "absolutely bonkers."
MLAB's breakout is attributed to its printing money and feeling unstoppable, with the stock hitting targets and experiencing a rocket-like rise to the moon.

Generated by AI

Topics

Of the messages about MLAB that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	84.85%
Analysts	—	—	0%	0%
Controversies	—	—	0%	3.03%
Earnings	—	—	0%	3.03%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	9.09%

Earnings· Jul 31

Mesa Laboratories, Inc. reported Q1 EPS of $1.06 and revenue of $25.14M, a 10.9% year-over-year increase.
The company's stock price rose 2.85% following the announcement of Q1 earnings.
Mesa Laboratories' Q1 earnings per share (EPS) came in at $1.06, beating expectations.

Announcements· May 31

Mesa Laboratories, Inc. has revised its earnings announcement date for the unaudited fourth quarter and full fiscal year 2024 results.
Trading in $MLAB was halted for the first time on May 31, 2024, due to volatility, but resumed shortly after.
Mesa Laboratories, Inc. recently went ex-dividend, which may be related to the recent price movement in the stock.

Generated by AI

Community

Of the messages about MLAB, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	12%	38.16%
Newcomers	—	100%	88%	61.84%

Regulars· Feb 6

Mesa Laboratories reported earnings of $1.96, beating the consensus estimate of $1.49.
The company's Non-GAAP EPS of $2.35 beat expectations, while revenue of $54.29M missed the estimate of $57.04M.
Mesa Laboratories' CEO or Director, John James Sullivan, gifted 14,580 shares of common stock to himself at a price of $0, increasing his holdings to 44,580 shares.

Newcomers· Jul 23

The asset, Mesa Laboratories Inc. (MLAB), is experiencing a significant surge, with its price increasing by 1.09% to $98.57, causing excitement among investors.
The newcomers are attributing the asset's rally to its "crazy surge" and "printing money" vibes, with some users joking about the asset going "to the moon".
The asset's momentum is described as "nuts", "insane", and "absolutely bonkers", with users expressing their excitement and enthusiasm for the stock's rapid growth.

Generated by AI

Mesa Laboratories

Social

Jul 23

Jul 23

Earnings· Jul 31

Announcements· May 31

Regulars· Feb 6

Newcomers· Jul 23

Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript

Mesa Laboratories CEO Kadia buys $800,090 in stock

Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary

Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: Margin Expansion and Debt ...

Mesa Laboratories Q1 Earnings Call Highlights

Earnings call transcript: Mesa Laboratories posts Q1 2026 revenue miss

Also Discussed

Mesa Laboratories, Inc.

Company Information

Location

Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript

Mesa Laboratories CEO Kadia buys $800,090 in stock

Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary

Mesa Laboratories Inc (MLAB) (Q1 2027) Earnings Call Highlights: Margin Expansion and Debt ...

Mesa Laboratories Q1 Earnings Call Highlights

Earnings call transcript: Mesa Laboratories posts Q1 2026 revenue miss

Also Discussed

Social

Jul 23

Jul 23

Earnings· Jul 31

Announcements· May 31

Regulars· Feb 6

Newcomers· Jul 23